| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6291223cb0754d524a5f6d760cd8ed76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
| filingDate |
2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3875c59de6134c50265495bd5232876c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ddf5629d18352ca5514dc5e60df48fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_339c35363ebed2eda54c630a3daec040
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3566a3f0c566a1714233fdd51e845d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb8c17cf5c5bdda271efb76500bfb7fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba44cb6d86f337de0e97e8bf6d3ee29 |
| publicationDate |
2008-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008194700-A1 |
| titleOfInvention |
Use of Paeonol For Inhibiting Angiogenesis or For Enhancing Radiosensitization |
| abstract |
The present invention relates to a composition comprising paeonol of formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient for inhibiting angiogenesis, or for enhancing radiosensitization. The present invention also relates to novel use of paeonol of formula (I) or a pharmaceutically acceptable salt thereof for the manufacture of a composition for inhibiting angiogenesis, or for the manufacture of a composition for enhancing radiosensitization. Also, the present invention relates to a method for inhibiting angiogenesis which comprises administrating to a subject in need thereof an effective amount of paeonol of formula (I) or a pharmaceutically acceptable salt thereof, or a method for enhancing radiosensitization which comprises administrating an effective amount of paeonol of formula (I) or pharmaceutically acceptable salts thereof to a subject in need of radiotherapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102349926-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102166205-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106727454-A |
| priorityDate |
2005-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |